Ionis, AstraZeneca get FDA approval for rare genetic disease treatment

Ionis Pharmaceuticals IONS, and AstraZeneca’s AZN, Wainua has been approved by the U.S. Food and Drug Administration for treating a symptom of a rare genetic disease. The FDA approved Wainua, which has generic name eplontersen, for the treatment of the polyneuropathy of hereditary…#astrazenecas #azn #wainua #fda #ionis
Source: Reuters: Health - Category: Consumer Health News Source Type: news